Please login to the form below

Not currently logged in
Email:
Password:

Affimed

This page shows the latest Affimed news and features for those working in and with pharma, biotech and healthcare.

Xencor’s Novartis-partnered bispecific on hold after patient deaths

Xencor’s Novartis-partnered bispecific on hold after patient deaths

In this case however the concerns were about liver toxicity. A few weeks earlier a trial of Affimed’s CD3- and CD19-targeting bispecific AFM11 in non-Hodgkin’s lymphoma was

Latest news

  • Affimed rockets on $5bn-plus Roche immuno-oncology deal Affimed rockets on $5bn-plus Roche immuno-oncology deal

    German biotech Affimed saw its share price more than triple yesterday after Roche’s Genentech agreed an alliance to discover new cancer immunotherapies with a jaw-dropping milestone figure. ... Roche is paying $96m in upfront and near-term funding

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics